Report Detail

Pharma & Healthcare Global Chorionic Gonadotrophin for Injection Market Growth 2022-2028

  • RnM4475175
  • |
  • 02 August, 2022
  • |
  • Global
  • |
  • 105 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

The global market for Chorionic Gonadotrophin for Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Chorionic Gonadotrophin for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Chorionic Gonadotrophin for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Chorionic Gonadotrophin for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Chorionic Gonadotrophin for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Chorionic Gonadotrophin for Injection players cover Beijing Science Sun Pharmaceutical, Shenyang EverBright Pharmaceutical, Yantai Dongcheng Beifang Pharmaceutical, Livzon Pharmaceutical Group and Ningbo Renjian Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Chorionic Gonadotrophin for Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Chorionic Gonadotrophin for Injection market, with both quantitative and qualitative data, to help readers understand how the Chorionic Gonadotrophin for Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:
The study segments the Chorionic Gonadotrophin for Injection market and forecasts the market size by Specification (1000U/Piece, 2000U/Piece and 5000U/Piece), by Application (Hospital Pharmacy, Retail Pharmacy and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by specification
1000U/Piece
2000U/Piece
5000U/Piece

Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Beijing Science Sun Pharmaceutical
Shenyang EverBright Pharmaceutical
Yantai Dongcheng Beifang Pharmaceutical
Livzon Pharmaceutical Group
Ningbo Renjian Pharmaceutical
Ma'anshan Fengyuan Pharmaceutical
Harbin High-Tech Group Baitian'er Pharmaceutical
Sinopharm
Besins Healthcare Benelux
Bristol Myers Squibb
Organon

Chapter Introduction
Chapter 1: Scope of Chorionic Gonadotrophin for Injection, Research Methodology, etc.
Chapter 2: Executive Summary, global Chorionic Gonadotrophin for Injection market size (sales and revenue) and CAGR, Chorionic Gonadotrophin for Injection market size by region, by specification, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Chorionic Gonadotrophin for Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Chorionic Gonadotrophin for Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by specification, and specification.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Chorionic Gonadotrophin for Injection market size forecast by region, by country, by specification, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Beijing Science Sun Pharmaceutical, Shenyang EverBright Pharmaceutical, Yantai Dongcheng Beifang Pharmaceutical, Livzon Pharmaceutical Group, Ningbo Renjian Pharmaceutical, Ma'anshan Fengyuan Pharmaceutical, Harbin High-Tech Group Baitian'er Pharmaceutical, Sinopharm and Besins Healthcare Benelux, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Chorionic Gonadotrophin for Injection Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Chorionic Gonadotrophin for Injection by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Chorionic Gonadotrophin for Injection by Country/Region, 2017, 2022 & 2028
  • 2.2 Chorionic Gonadotrophin for Injection Segment by Specification
    • 2.2.1 1000U/Piece
    • 2.2.2 2000U/Piece
    • 2.2.3 5000U/Piece
  • 2.3 Chorionic Gonadotrophin for Injection Sales by Specification
    • 2.3.1 Global Chorionic Gonadotrophin for Injection Sales Market Share by Specification (2017-2022)
    • 2.3.2 Global Chorionic Gonadotrophin for Injection Revenue and Market Share by Specification (2017-2022)
    • 2.3.3 Global Chorionic Gonadotrophin for Injection Sale Price by Specification (2017-2022)
  • 2.4 Chorionic Gonadotrophin for Injection Segment by Application
    • 2.4.1 Hospital Pharmacy
    • 2.4.2 Retail Pharmacy
    • 2.4.3 Others
  • 2.5 Chorionic Gonadotrophin for Injection Sales by Application
    • 2.5.1 Global Chorionic Gonadotrophin for Injection Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Chorionic Gonadotrophin for Injection Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Chorionic Gonadotrophin for Injection Sale Price by Application (2017-2022)

3 Global Chorionic Gonadotrophin for Injection by Company

  • 3.1 Global Chorionic Gonadotrophin for Injection Breakdown Data by Company
    • 3.1.1 Global Chorionic Gonadotrophin for Injection Annual Sales by Company (2020-2022)
    • 3.1.2 Global Chorionic Gonadotrophin for Injection Sales Market Share by Company (2020-2022)
  • 3.2 Global Chorionic Gonadotrophin for Injection Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Chorionic Gonadotrophin for Injection Revenue by Company (2020-2022)
    • 3.2.2 Global Chorionic Gonadotrophin for Injection Revenue Market Share by Company (2020-2022)
  • 3.3 Global Chorionic Gonadotrophin for Injection Sale Price by Company
  • 3.4 Key Manufacturers Chorionic Gonadotrophin for Injection Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Chorionic Gonadotrophin for Injection Product Location Distribution
    • 3.4.2 Players Chorionic Gonadotrophin for Injection Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Chorionic Gonadotrophin for Injection by Geographic Region

  • 4.1 World Historic Chorionic Gonadotrophin for Injection Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Chorionic Gonadotrophin for Injection Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Chorionic Gonadotrophin for Injection Annual Revenue by Geographic Region
  • 4.2 World Historic Chorionic Gonadotrophin for Injection Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Chorionic Gonadotrophin for Injection Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Chorionic Gonadotrophin for Injection Annual Revenue by Country/Region
  • 4.3 Americas Chorionic Gonadotrophin for Injection Sales Growth
  • 4.4 APAC Chorionic Gonadotrophin for Injection Sales Growth
  • 4.5 Europe Chorionic Gonadotrophin for Injection Sales Growth
  • 4.6 Middle East & Africa Chorionic Gonadotrophin for Injection Sales Growth

5 Americas

  • 5.1 Americas Chorionic Gonadotrophin for Injection Sales by Country
    • 5.1.1 Americas Chorionic Gonadotrophin for Injection Sales by Country (2017-2022)
    • 5.1.2 Americas Chorionic Gonadotrophin for Injection Revenue by Country (2017-2022)
  • 5.2 Americas Chorionic Gonadotrophin for Injection Sales by Specification
  • 5.3 Americas Chorionic Gonadotrophin for Injection Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Chorionic Gonadotrophin for Injection Sales by Region
    • 6.1.1 APAC Chorionic Gonadotrophin for Injection Sales by Region (2017-2022)
    • 6.1.2 APAC Chorionic Gonadotrophin for Injection Revenue by Region (2017-2022)
  • 6.2 APAC Chorionic Gonadotrophin for Injection Sales by Specification
  • 6.3 APAC Chorionic Gonadotrophin for Injection Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Chorionic Gonadotrophin for Injection by Country
    • 7.1.1 Europe Chorionic Gonadotrophin for Injection Sales by Country (2017-2022)
    • 7.1.2 Europe Chorionic Gonadotrophin for Injection Revenue by Country (2017-2022)
  • 7.2 Europe Chorionic Gonadotrophin for Injection Sales by Specification
  • 7.3 Europe Chorionic Gonadotrophin for Injection Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Chorionic Gonadotrophin for Injection by Country
    • 8.1.1 Middle East & Africa Chorionic Gonadotrophin for Injection Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Chorionic Gonadotrophin for Injection Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Chorionic Gonadotrophin for Injection Sales by Specification
  • 8.3 Middle East & Africa Chorionic Gonadotrophin for Injection Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Chorionic Gonadotrophin for Injection
  • 10.3 Manufacturing Process Analysis of Chorionic Gonadotrophin for Injection
  • 10.4 Industry Chain Structure of Chorionic Gonadotrophin for Injection

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Chorionic Gonadotrophin for Injection Distributors
  • 11.3 Chorionic Gonadotrophin for Injection Customer

12 World Forecast Review for Chorionic Gonadotrophin for Injection by Geographic Region

  • 12.1 Global Chorionic Gonadotrophin for Injection Market Size Forecast by Region
    • 12.1.1 Global Chorionic Gonadotrophin for Injection Forecast by Region (2023-2028)
    • 12.1.2 Global Chorionic Gonadotrophin for Injection Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Chorionic Gonadotrophin for Injection Forecast by Specification
  • 12.7 Global Chorionic Gonadotrophin for Injection Forecast by Application

13 Key Players Analysis

  • 13.1 Beijing Science Sun Pharmaceutical
    • 13.1.1 Beijing Science Sun Pharmaceutical Company Information
    • 13.1.2 Beijing Science Sun Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
    • 13.1.3 Beijing Science Sun Pharmaceutical Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Beijing Science Sun Pharmaceutical Main Business Overview
    • 13.1.5 Beijing Science Sun Pharmaceutical Latest Developments
  • 13.2 Shenyang EverBright Pharmaceutical
    • 13.2.1 Shenyang EverBright Pharmaceutical Company Information
    • 13.2.2 Shenyang EverBright Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
    • 13.2.3 Shenyang EverBright Pharmaceutical Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Shenyang EverBright Pharmaceutical Main Business Overview
    • 13.2.5 Shenyang EverBright Pharmaceutical Latest Developments
  • 13.3 Yantai Dongcheng Beifang Pharmaceutical
    • 13.3.1 Yantai Dongcheng Beifang Pharmaceutical Company Information
    • 13.3.2 Yantai Dongcheng Beifang Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
    • 13.3.3 Yantai Dongcheng Beifang Pharmaceutical Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Yantai Dongcheng Beifang Pharmaceutical Main Business Overview
    • 13.3.5 Yantai Dongcheng Beifang Pharmaceutical Latest Developments
  • 13.4 Livzon Pharmaceutical Group
    • 13.4.1 Livzon Pharmaceutical Group Company Information
    • 13.4.2 Livzon Pharmaceutical Group Chorionic Gonadotrophin for Injection Product Offered
    • 13.4.3 Livzon Pharmaceutical Group Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Livzon Pharmaceutical Group Main Business Overview
    • 13.4.5 Livzon Pharmaceutical Group Latest Developments
  • 13.5 Ningbo Renjian Pharmaceutical
    • 13.5.1 Ningbo Renjian Pharmaceutical Company Information
    • 13.5.2 Ningbo Renjian Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
    • 13.5.3 Ningbo Renjian Pharmaceutical Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Ningbo Renjian Pharmaceutical Main Business Overview
    • 13.5.5 Ningbo Renjian Pharmaceutical Latest Developments
  • 13.6 Ma'anshan Fengyuan Pharmaceutical
    • 13.6.1 Ma'anshan Fengyuan Pharmaceutical Company Information
    • 13.6.2 Ma'anshan Fengyuan Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
    • 13.6.3 Ma'anshan Fengyuan Pharmaceutical Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Ma'anshan Fengyuan Pharmaceutical Main Business Overview
    • 13.6.5 Ma'anshan Fengyuan Pharmaceutical Latest Developments
  • 13.7 Harbin High-Tech Group Baitian'er Pharmaceutical
    • 13.7.1 Harbin High-Tech Group Baitian'er Pharmaceutical Company Information
    • 13.7.2 Harbin High-Tech Group Baitian'er Pharmaceutical Chorionic Gonadotrophin for Injection Product Offered
    • 13.7.3 Harbin High-Tech Group Baitian'er Pharmaceutical Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Harbin High-Tech Group Baitian'er Pharmaceutical Main Business Overview
    • 13.7.5 Harbin High-Tech Group Baitian'er Pharmaceutical Latest Developments
  • 13.8 Sinopharm
    • 13.8.1 Sinopharm Company Information
    • 13.8.2 Sinopharm Chorionic Gonadotrophin for Injection Product Offered
    • 13.8.3 Sinopharm Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Sinopharm Main Business Overview
    • 13.8.5 Sinopharm Latest Developments
  • 13.9 Besins Healthcare Benelux
    • 13.9.1 Besins Healthcare Benelux Company Information
    • 13.9.2 Besins Healthcare Benelux Chorionic Gonadotrophin for Injection Product Offered
    • 13.9.3 Besins Healthcare Benelux Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Besins Healthcare Benelux Main Business Overview
    • 13.9.5 Besins Healthcare Benelux Latest Developments
  • 13.10 Bristol Myers Squibb
    • 13.10.1 Bristol Myers Squibb Company Information
    • 13.10.2 Bristol Myers Squibb Chorionic Gonadotrophin for Injection Product Offered
    • 13.10.3 Bristol Myers Squibb Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Bristol Myers Squibb Main Business Overview
    • 13.10.5 Bristol Myers Squibb Latest Developments
  • 13.11 Organon
    • 13.11.1 Organon Company Information
    • 13.11.2 Organon Chorionic Gonadotrophin for Injection Product Offered
    • 13.11.3 Organon Chorionic Gonadotrophin for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Organon Main Business Overview
    • 13.11.5 Organon Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Chorionic Gonadotrophin for Injection. Industry analysis & Market Report on Chorionic Gonadotrophin for Injection is a syndicated market report, published as Global Chorionic Gonadotrophin for Injection Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Chorionic Gonadotrophin for Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,015.84
6,031.68
3,564.84
7,129.68
488,646.60
977,293.20
291,372.60
582,745.20
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report